The DOI matches its Crossref record; 147 of the 147 references it cites were found in a registry or an index.
Cyclooxygenase‐2 in cancer: A review
Abstract
Cyclooxygenase‐2 (COX‐2) is frequently expressed in many types of cancers exerting a pleiotropic and multifaceted role in genesis or promotion of carcinogenesis and cancer cell resistance to chemo‐ and radiotherapy. COX‐2 is released by cancer‐associated fibroblasts (CAFs), macrophage type 2 (M2) cells, and cancer cells to the tumor microenvironment (TME). COX‐2 induces cancer stem cell (CSC)‐like activity, and promotes apoptotic resistance, proliferation, angiogenesis, inflammation, invasion, and metastasis of cancer cells. COX‐2 mediated hypoxia within the TME along with its positive interactions with YAP1 and antiapoptotic mediators are all in favor of cancer cell resistance to chemotherapeutic drugs. COX‐2 exerts most of the functions through its metabolite prostaglandin E2. In some and limited situations, COX‐2 may act as an antitumor enzyme. Multiple signals are contributed to the functions of COX‐2 on cancer cells or its regulation. Members of mitogen‐activated protein kinase (MAPK) family, epidermal growth factor receptor (EGFR), and nuclear factor‐κβ are main upstream modulators for COX‐2 in cancer cells. COX‐2 also has interactions with a number of hormones within the body. Inhibition of COX‐2 provides a high possibility to exert therapeutic outcomes in cancer. Administration of COX‐2 inhibitors in a preoperative setting could reduce the risk of metastasis in cancer patients. COX‐2 inhibition also sensitizes cancer cells to treatments like radio‐ and chemotherapy. Chemotherapeutic agents adversely induce COX‐2 activity. Therefore, choosing an appropriate chemotherapy drugs along with adjustment of the type and does for COX‐2 inhibitors based on the type of cancer would be an effective adjuvant strategy for targeting cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Zhao, J. J., Zhu, J., Lv, X., Xing, J., Liu, S., Chen, C., & Xu, Y. (2017) · OncoTargets and Therapy · doi:10.2147/ott.s149708 · Cited by 45
RetractedGreenhough, A., Smartt, H. J. M., Moore, A. E., Roberts, H. R., Williams, A. C., Paraskeva, C., & Kaidi, A. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp014 · Cited by 1,220
Sharma, S., Yang, S.-C., Zhu, L., Reckamp, K., Gardner, B., Baratelli, F., Huang, M., Batra, R. K., & Dubinett, S. M. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0141 · Cited by 506
Fritsche, E., Schäfer, C., Calles, C., Bernsmann, T., Bernshausen, T., Wurm, M., Hübenthal, U., Cline, J. E., Hajimiragha, H., Schroeder, P., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0701764104 · Cited by 437
Cyclooxygenase-2 and Epidermal Growth Factor Receptor: Pharmacologic Targets for Chemoprevention
Dannenberg, A. J., Lippman, S. M., Mann, J. R., Subbaramaiah, K., & DuBois, R. N. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.09.112 · Cited by 404
Targeting Inflammation in Cancer Prevention and Therapy
Todoric, J., Antonucci, L., & Karin, M. (2016) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-16-0209 · Cited by 354
Tjiu, J.-W., Chen, J.-S., Shun, C.-T., Lin, S.-J., Liao, Y.-H., Chu, C.-Y., Tsai, T.-F., Chiu, H.-C., Dai, Y.-S., Inoue, H., et al. (2009) · Journal of Investigative Dermatology · doi:10.1038/jid.2008.310 · Cited by 342
Regulation of cyclooxygenase-2 expression by the Wnt and ras pathways.
Araki, Y., Okamura, S., Hussain, S. P., Nagashima, M., He, P., Shiseki, M., Miura, K., & Harris, C. C. (2003) · PubMed · Cited by 322
Cell signalling by reactive lipid species: new concepts and molecular mechanisms
Higdon, A., Diers, A. R., Oh, J. Y., Landar, A., & Darley-Usmar, V. M. (2012) · Biochemical Journal · doi:10.1042/bj20111752 · Cited by 317
Shaashua, L., Shabat-Simon, M., Haldar, R., Matzner, P., Zmora, O., Shabtai, M., Sharon, E., Allweis, T., Barshack, I., Hayman, L., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-0152 · Cited by 276
Altorki, N. K., Keresztes, R. S., Port, J. L., Libby, D. M., Korst, R. J., Flieder, D. B., Ferrara, C. A., Yankelevitz, D. F., Subbaramaiah, K., Pasmantier, M. W., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.07.127 · Cited by 275
Desai, S. J., Prickril, B., & Rasooly, A. (2018) · Nutrition and Cancer · doi:10.1080/01635581.2018.1446091 · Cited by 274
Hung, J.-H., Su, I.-J., Lei, H.-Y., Wang, H.-C., Lin, W.-C., Chang, W.-T., Huang, W., Chang, W.-C., Chang, Y.-S., Chen, C.-C., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403568200 · Cited by 257
Inflammasome: Its role in traumatic brain and spinal cord injury
Mortezaee, K., Khanlarkhani, N., Beyer, C., & Zendedel, A. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.26287 · Cited by 251
Self-citationXiang, W., Shi, R., Kang, X., Zhang, X., Chen, P., Zhang, L., Hou, A., Wang, R., Zhao, Y., Zhao, K., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04999-8 · Cited by 243
O’Brien, K. P., Khan, S., Gilligan, K. E., Zafar, H., Lalor, P., Glynn, C., O’Flatharta, C., Ingoldsby, H., Dockery, P., De Bhulbh, A., et al. (2018) · Oncogene · doi:10.1038/s41388-017-0116-9 · Cited by 215
Wang, D., Buchanan, F. G., Wang, H., Dey, S. K., & DuBois, R. N. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3671 · Cited by 193
Nakanishi, Y., Nakatsuji, M., Seno, H., Ishizu, S., Akitake-Kawano, R., Kanda, K., Ueo, T., Komekado, H., Kawada, M., Minami, M., et al. (2011) · Carcinogenesis · doi:10.1093/carcin/bgr128 · Cited by 190
Cyclo‐oxygenase‐2 Plays a Critical Role in UV‐induced Skin Carcinogenesis†
Rundhaug, J. E., & Fischer, S. M. (2008) · Photochemistry and Photobiology · doi:10.1111/j.1751-1097.2007.00261.x · Cited by 173
Hennequart, M., Pilotte, L., Cane, S., Hoffmann, D., Stroobant, V., Plaen, E. D., & Eynde, B. J. V. D. (2017) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-16-0400 · Cited by 171
Thiazoles and Thiazolidinones as COX/LOX Inhibitors
Liaras, K., Fesatidou, M., & Geronikaki, A. (2018) · Molecules · doi:10.3390/molecules23030685 · Cited by 162
Xiao, F., Yu, Y., He, S., Cheng, J. Q., Gong, Y., Zhang, Z., Yang, X., Xu, B., Liu, X., Li, C., et al. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.10.042 · Cited by 158
C-Phycocyanin exerts anti-cancer effects via the MAPK signaling pathway in MDA-MB-231 cells
Jiang, L., Wang, Y., Liu, G., Liu, H., Zhu, F., Ji, H., & Li, B. (2018) · Cancer Cell International · doi:10.1186/s12935-018-0511-5 · Cited by 150
Henry, W. S., Laszewski, T., Tsang, T., de Beça, F. F., Beck, A. H., McAllister, S. S., & Toker, A. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-2400 · Cited by 140
Cai, T., Ye, S., Liu, Y.-N., He, J., Chen, Q.-Y., Mai, H., Zhang, C.-X., Cui, J., Zhang, X.-S., Busson, P., et al. (2017) · PLoS Pathogens · doi:10.1371/journal.ppat.1006503 · Cited by 138
Liu, W., Reinmuth, N., Stoeltzing, O., Parikh, A. A., Tellez, C. S., Williams, S. A., Jung, Y. D., Fan, F., Takeda, A., Akagi, M., et al. (2003) · PubMed · Cited by 135
Esbona, K., Yi, Y., Saha, S., Yu, M., Doorn, R. R. V., Conklin, M. W., Graham, D., Wisinski, K. B., Ponik, S. M., Eliceiri, K. W., et al. (2018) · American Journal Of Pathology · doi:10.1016/j.ajpath.2017.10.025 · Cited by 135
Cyclooxygenase-2 in glioblastoma multiforme
Qiu, J., Shi, Z., & Jiang, J. (2016) · Drug Discovery Today · doi:10.1016/j.drudis.2016.09.017 · Cited by 134
Metformin inhibits castration-induced EMT in prostate cancer by repressing COX2/PGE2/STAT3 axis
Tong, D., Liu, Q., Liu, G., Xu, J., Lan, W., Jiang, Y., Xiao, H., Zhang, D., & Jiang, J. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.12.031 · Cited by 134
Endothelial cell integrins and COX-2: mediators and therapeutic targets of tumor angiogenesis
Rüegg, C., Dormond, O., & Mariotti, A. (2003) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2003.09.003 · Cited by 130
COX-2 modulates mammary tumor progression in response to collagen density
Esbona, K., Inman, D. R., Saha, S., Jeffery, J. J., Schedin, P. S., Wilke, L. G., & Keely, P. J. (2016) · Breast Cancer Research · doi:10.1186/s13058-016-0695-3 · Cited by 128
Li, B., Lü, Y., Yu, L., Han, X., Wang, H., Mao, J., Shen, J., Tang, J., Tang, J., Li, C., et al. (2017) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2017.08.014 · Cited by 120
Chen, H., Cai, W., Chu, E. S., Tang, J. T., Wong, C.-C., Wong, S. H., Sun, W., Liang, Q., Fang, J., Sun, Z., et al. (2017) · Oncogene · doi:10.1038/onc.2017.73 · Cited by 118
Theodoraki, M., Hoffmann, T. K., & Whiteside, T. L. (2018) · Clinical & Experimental Immunology · doi:10.1111/cei.13113 · Cited by 116
Lu, J.-J., Fu, L., Tang, Z., Zhang, C., Qin, L., Wang, J., Yu, Z., Shi, D., Xiao, X., Xie, F., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.6407 · Cited by 114
Hu, H. X., Han, T., Zhuo, M., Wu, L., Yuan, C., Wu, L., Wang, L., Jiao, F., & Wang, L. (2017) · Scientific Reports · doi:10.1038/s41598-017-00288-4 · Cited by 111
Autophagy gene ATG7 regulates ultraviolet radiation-induced inflammation and skin tumorigenesis
Qiang, L., Sample, A., Shea, C. R., Soltani, K., Macleod, K. F., & He, Y. (2017) · Autophagy · doi:10.1080/15548627.2017.1380757 · Cited by 111
Liu, Y., Borchert, G. L., Surażyński, A., & Phang, J. M. (2008) · Oncogene · doi:10.1038/onc.2008.322 · Cited by 108
COX-2 inhibitors: a novel strategy in the management of breast cancer
Regulski, M., Regulska, K., Prukała, W., PIOTROWSKA, H., Stanisz, B. J., & Murias, M. (2015) · Drug Discovery Today · doi:10.1016/j.drudis.2015.12.003 · Cited by 103
Melatonin application in targeting oxidative‐induced liver injuries: A review
Mortezaee, K., & Khanlarkhani, N. (2017) · Journal of Cellular Physiology · doi:10.1002/jcp.26209 · Cited by 101
Self-citationYue, X., Nguyen, T. D., Zellmer, V., Zhang, S., & Zorlutuna, P. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.04.001 · Cited by 97
Dong, X., Liu, T., Zhi, X., Zou, J., Zhong, J., Li, T., Mo, X.-L., Zhou, W., Guo, W., Liu, X., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-2725 · Cited by 95
Yang, H., Huang, S., Wei, Y., Cao, S., Pi, C., Feng, T., Liang, J., Zhao, L., & Ren, G. (2017) · Journal of Cancer · doi:10.7150/jca.20196 · Cited by 94
Hinz, B., Ramer, R., Eichele, K., Weinzierl, U., & Brune, K. (2004) · Molecular Pharmacology · doi:10.1124/mol.104.002618 · Cited by 93
Cancer Chemoprevention by Cyclooxygenase 2 (COX-2) Blockade: Results of case control studies
Harris, R. E., Beebe-Donk, J., & Alshafie, G. A. (2007) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/1-4020-5688-5_9 · Cited by 91
Inhibition of Nr4a Receptors Enhances Antitumor Immunity by Breaking Treg-Mediated Immune Tolerance
Hibino, S., Chikuma, S., Kondo, T., Ito, M., Nakatsukasa, H., Omata‐Mise, S., & Yoshimura, A. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-3102 · Cited by 90
The Colorectal Cancer Study Group, Charalambous, M. P., Maihöfner, C., Bhambra, U., Lightfoot, T., & Gooderham, N. J. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6600927 · Cited by 87
Sorski, L., Melamed, R., Matzner, P., Lavon, H., Shaashua, L., Rosenne, E., & Ben-Eliyahu, S. (2016) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2016.05.017 · Cited by 85
Cook, P. J., Thomas, R., Kingsley, P. J., Shimizu, F., Montrose, D. C., Marnett, L. J., Tabar, V. S., Dannenberg, A. J., & Benezra, R. (2016) · Neuro-Oncology · doi:10.1093/neuonc/now049 · Cited by 83
Qin, G., Xu, F., Qin, T., Zheng, Q., Shi, D., Xia, W., Tian, Y., Tang, Y., Wang, J., Xiao, X., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.5993 · Cited by 81
Gan, L., Qiu, Z., Huang, J., Li, Y., Huang, H., Xiang, T., Wan, J., Hui, T., Lin, Y. S., Li, H., et al. (2016) · International Journal of Biological Sciences · doi:10.7150/ijbs.15943 · Cited by 79
Proton irradiation orchestrates macrophage reprogramming through NFκB signaling
Genard, G., Wéra, A.-C., Huart, C., Calvé, B. L., Penninckx, S., Fattaccioli, A., Tabarrant, T., Demazy, C., Ninane, N., Heuskin, A., et al. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0757-9 · Cited by 79
Overexpression of Cox-2 in Human Osteosarcoma Cells Decreases Proliferation and Increases Apoptosis
Zheng, X., Choudhary, S., Voznesensky, O. S., Mehrotra, M., Woodard, M., Hansen, M. F., Herschman, H. R., & Pilbeam, C. C. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3624 · Cited by 78
Kabir, T. D., Leigh, R. J., Tasena, H., Mellone, M., Coletta, R. D., Parkinson, E. K., Prime, S. S., Thomas, G. J., Paterson, I. C., Zhou, D., et al. (2016) · Aging · doi:10.18632/aging.100987 · Cited by 78
Rong, X., Huang, B., Qiu, S., Li, X., He, L., & Peng, Y. (2016) · Oncotarget · doi:10.18632/oncotarget.6930 · Cited by 78
Wang, X., Yu, Z., Wang, C., Cheng, W., Tian, X., Huo, X., Wang, Y., Sun, C., Feng, L., Xing, J., et al. (2017) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-017-0563-8 · Cited by 78
Zhou, T., Zhang, S.-L., He, C., Zhuang, Q.-Y., Han, P., Jiang, S., Yao, H., Huang, Y., Ling, W., Lin, Y., et al. (2017) · Theranostics · doi:10.7150/thno.17647 · Cited by 77
Hattar, K., Franz, K., Ludwig, M., Sibelius, U., Wilhelm, J., Lohmeyer, J., Savai, R., Subtil, F. S. B., Dahlem, G., Eul, B. G., et al. (2014) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-014-1606-z · Cited by 75
Kim, E. H., Na, H., Kim, D., Park, S., Kim, H., Song, N., & Surh, Y. (2008) · Carcinogenesis · doi:10.1093/carcin/bgm299 · Cited by 75
Pre-clinical effects of metformin and aspirin on the cell lines of different breast cancer subtypes
Amaral, M. E. A., Nery, L. R., Leite, C. E., de Azevedo, W. F., & Campos, M. M. (2018) · Investigational New Drugs · doi:10.1007/s10637-018-0568-y · Cited by 75
Epinephrine promotes COX-2-dependent immune suppression in myeloid cells and cancer tissues
Muthuswamy, R., Okada, N. J., Jenkins, F. J., McGuire, K. P., McAuliffe, P. F., Zeh, H. J., Bartlett, D. L., Wallace, C. T., Watkins, S. C., Henning, J. D., et al. (2017) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2017.02.008 · Cited by 73
Yadav, D. K., Kumar, S., Saloni, S., Misra, S., Yadav, L., Teli, M. K., Sharma, P., Chaudhary, S., Kumar, N., Choi, E. H., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-22972-9 · Cited by 73
Cyclooxygenase-2 regulates TGFβ-induced cancer stemness in triple-negative breast cancer
Tian, J., Hachim, M. Y., Hachim, I. Y., Dai, M., Lo, C., Raffa, F. A., Ali, S., & Lebrun, J. J. (2017) · Scientific Reports · doi:10.1038/srep40258 · Cited by 72
Human hepatocellular carcinoma: Protection by melatonin
Mortezaee, K. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.26586 · Cited by 72
Self-citationHypoxia-Induced Downregulation of DUSP-2 Phosphatase Drives Colon Cancer Stemness
Hou, P., Li, Y.-H., Lin, S., Lin, S.-C., Lee, J., Lin, B.-W., Liou, J., Chang, J., Kuo, C., Liu, Y.-M., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-2990 · Cited by 71
COX-2 Elevates Oncogenic miR-526b in Breast Cancer by EP4 Activation
Majumder, M., Landman, E., Liu, L., Hess, D. A., & Lala, P. K. (2015) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-14-0543 · Cited by 70
Krishnamachary, B., Stasinopoulos, I. A., Kakkad, S. M., Penet, M., Jacob, D., Wildes, F. B., Mironchik, Y., Pathak, A. P., Solaiyappan, M., & Bhujwalla, Z. M. (2017) · Oncotarget · doi:10.18632/oncotarget.14912 · Cited by 70
Behrenbruch, C., Shembrey, C., Paquet‐Fifield, S., Mølck, C., Cho, H., Michael, M., Thomson, B. N. J., Heriot, A. G., & Hollande, F. (2018) · Clinical & Experimental Metastasis · doi:10.1007/s10585-018-9873-2 · Cited by 70
Thyroxine inhibits resveratrol-caused apoptosis by PD-L1 in ovarian cancer cells
Chin, Y., Wei, P., Ho, Y., Nana, A. W., Changou, C. A., Chen, Y., Yang, Y. S. H., Hsieh, M.-T., Hercbergs, A. A., Davis, P. J., et al. (2018) · Endocrine Related Cancer · doi:10.1530/erc-17-0376 · Cited by 67
Miao, J., Xu, L., Hu, Y., Piao, C., Wu, X., Liu, X., Huang, C., Wang, Y., Li, D., & Liu, J. (2017) · Oncotarget · doi:10.18632/oncotarget.21155 · Cited by 66
Lu, C., Laws, K., Eskandari, A., & Suntharalingam, K. (2017) · Dalton Transactions · doi:10.1039/c7dt02789c · Cited by 63
COX-2 induces oncogenic micro RNA miR655 in human breast cancer
Majumder, M., Dunn, L., Liu, L., Hasan, A., Vincent, K. M., Brackstone, M., Hess, D. A., & Lala, P. K. (2018) · Scientific Reports · doi:10.1038/s41598-017-18612-3 · Cited by 63
Reactive Lipid Species from Cyclooxygenase-2 Inactivate Tumor Suppressor LKB1/STK11
Wagner, T. M., Mullally, J. E., & Fitzpatrick, F. A. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m509723200 · Cited by 62
Hosseini, F. S., Mahdian-shakib, A., Jadidi‐Niaragh, F., Enderami, S. E., Mohammadi, H., Hemmatzadeh, M., Mohammed, H. A., Anissian, A., Kokhaei, P., Mirshafiey, A., et al. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.12.111 · Cited by 62
Sun, W., Chen, G., Ou, X., Yang, Y., Luo, C., Zhang, Y., Shao, Y., Xu, H., Xiao, B., Xue, Y.-P., et al. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.10.023 · Cited by 61
Lü, C., Eskandari, A., Cressey, P., & Suntharalingam, K. (2017) · Chemistry - A European Journal · doi:10.1002/chem.201701939 · Cited by 58
Ramu, A. K., Kathiresan, S., Ramadoss, H., Nallu, A., Kaliyan, R., & Azhamuthu, T. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.12.049 · Cited by 57
Lovastatin lactone elicits human lung cancer cell apoptosis via a COX-2/PPARγ-dependent pathway
Walther, U. I., Emmrich, K., Ramer, R., Mittag, N., & Hinz, B. (2016) · Oncotarget · doi:10.18632/oncotarget.7213 · Cited by 56
Zhao, Y., Cui, L., Pan, Y., Shao, D., Zheng, X., Zhang, F., Zhang, H., He, K., & Chen, L. (2017) · Cell Proliferation · doi:10.1111/cpr.12393 · Cited by 55
Li, W., Cao, Y., Xu, J., Wang, Y., Li, W., Wang, Q., Hu, Z., Hao, Y., Hu, L., Sun, Y., et al. (2017) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-017-0612-3 · Cited by 54
Das, U. B., Biswas, S., Chattopadhyay, S., Chakraborty, A., Sharma, R. D., Banerji, A., & Dey, S. (2017) · Scientific Reports · doi:10.1038/s41598-017-14211-4 · Cited by 53
Qiu, H., Wang, P., Li, Z., Ma, J., Wang, X., Yang, Y., & Zhu, H. (2015) · Pharmacological Research · doi:10.1016/j.phrs.2015.12.025 · Cited by 52
Chen, W., Bai, L., Wang, X., Xu, S., Belinsky, S. A., & Lin, Y. (2009) · Molecular Pharmacology · doi:10.1124/mol.109.061226 · Cited by 51
Yang, X., Xu, Y., Wang, T., Shu, D., Guo, P., Miskimins, K. W., & Qian, S. Y. (2017) · Redox Biology · doi:10.1016/j.redox.2017.01.016 · Cited by 51
LKB1 in lung cancerigenesis: a serine/threonine kinase as tumor suppressor
Gao, Y., Ge, G., & Ji, H. (2011) · Protein & Cell · doi:10.1007/s13238-011-1021-6 · Cited by 50
hnRNPA2/B1 activates cyclooxygenase‐2 and promotes tumor growth in human lung cancers
Yang, X., Wang, J., Ban, L., Lu, J.-J., Yi, C., Li, Z., Yu, W., Li, M., Xu, T., Yang, W., et al. (2015) · Molecular Oncology · doi:10.1016/j.molonc.2015.11.010 · Cited by 50
Eskandari, A., Boodram, J. N., Cressey, P., Lü, C., Bruno, P. M., Hemann, M. T., & Suntharalingam, K. (2016) · Dalton Transactions · doi:10.1039/c6dt03811e · Cited by 50
Maturu, P., Jones, D., Ruteshouser, E. C., Hu, Q., Reynolds, J. M., Hicks, J. M., Putluri, N., Ekmekçioglu, S., Grimm, E. A., Dong, C., et al. (2017) · Neoplasia · doi:10.1016/j.neo.2016.07.009 · Cited by 50
Chung, H. H., Or, Y. Z., Shrestha, S., Loh, J. T., Lim, C. L., Ong, Z., Woo, A. R. E., Su, I.-H., & Lin, V. C. L. (2017) · Scientific Reports · doi:10.1038/srep46485 · Cited by 50
The use of cyclooxygenase-2 inhibitors for improvement of efficacy of radiotherapy in cancers
Salehifar, E., & Hosseinimehr, S. J. (2016) · Drug Discovery Today · doi:10.1016/j.drudis.2016.02.019 · Cited by 49
Aberrantly activated Cox-2 and Wnt signaling interact to maintain cancer stem cells in glioblastoma
Wu, M., Guan, J., Li, C., Gunter, S. J., Nusrat, L., NG, S. C., Dhand, K., Morshead, C. M., Kim, A., & Das, S. (2017) · Oncotarget · doi:10.18632/oncotarget.19283 · Cited by 49
Celecoxib-Induced Self-Assembly of Smart Albumin-Doxorubicin Conjugate for Enhanced Cancer Therapy
Shi, L., Xu, L., Wu, C., Bai, X., Jin, X., Yang, J., & Zhu, X. (2018) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.8b00875 · Cited by 49
Lee, J. H., Suh, J. H., Choi, S. Y., Kang, H. J., Lee, H. H., Ye, B. J., Lee, G. R., Jung, S. W., Kim, C. J., Lee‐Kwon, W., et al. (2018) · Gut · doi:10.1136/gutjnl-2017-315348 · Cited by 48
MicroRNA-101 inhibits angiogenesis via COX-2 in endometrial carcinoma
Liu, Y., Li, H., Zhao, C., & Jia, H. (2018) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-018-3313-0 · Cited by 48
Ko, C., Lan, S.-W., Lu, Y.-C., Cheng, T.-S., Lai, P.-F., Tsai, C., Hsu, T.-W., Lin, H.-Y., Shyu, H.-Y., Wu, S.-R., et al. (2017) · Oncogene · doi:10.1038/onc.2017.82 · Cited by 46
Güngör, H., İlhan, N., & Eröksüz, H. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.03.066 · Cited by 46
Ohtsuka, J., Oshima, H., Ezawa, I., Abe, R., Oshima, M., & Ohki, R. (2018) · Scientific Reports · doi:10.1038/s41598-018-20572-1 · Cited by 46
Wang, J., Zou, K., Xu, F., Chen, M., Li, C., Tang, R., Yang, X., Luo, M., Chen, W., Qiu, H., et al. (2017) · Molecular Cancer · doi:10.1186/s12943-017-0705-9 · Cited by 45
Raj, V., Bhadauria, A. S., Singh, A. K., Kumar, U., Rai, A., Keshari, A. K., Kumar, P., Kumar, D., Maity, B., Nath, S., et al. (2018) · Cytokine · doi:10.1016/j.cyto.2018.03.026 · Cited by 45
Xu, Y., Yang, X., Wang, T., Yang, L., He, Y., Miskimins, K. W., & Qian, S. Y. (2018) · BMC Cancer · doi:10.1186/s12885-018-4250-8 · Cited by 45
Janakiraman, H., House, R. P., Talwar, S., Courtney, S. M., Hazard, E. S., Hardiman, G., Mehrotra, S., Howe, P. H., Gangaraju, V. K., & Palanisamy, V. (2016) · Oncogene · doi:10.1038/onc.2016.451 · Cited by 44
The ErbB family and androgen receptor signaling are targets of Celecoxib in prostate cancer
Brizzolara, A., Benelli, R., Venè, R., Barboro, P., Poggi, A. D., Tosetti, F., & Ferrari, N. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.04.025 · Cited by 44
Nöda, M., Tatsumi, Y., Tomizawa, M., Takama, T., Mitsufuji, S., Sugihara, H., Kashima, K., & Hattori, T. (2002) · Journal of Gastroenterology · doi:10.1007/s005350200151 · Cited by 43
Semaan, J., Pinon, A., Rioux, B., Hassan, L., Limami, Y., Pouget, C., Fagnère, C., Sol, V., Diab‐Assaf, M., Simon, A., et al. (2016) · Journal of Cellular Biochemistry · doi:10.1002/jcb.25600 · Cited by 43
Kim, E. H., & Surh, Y. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.07.043 · Cited by 41
COX-2 expression in ovarian cancer: an updated meta-analysis
Sun, H., Zhang, X., Sun, D., Jia, X., Xu, L., Qiao, Y., & Jin, Y. (2017) · Oncotarget · doi:10.18632/oncotarget.21538 · Cited by 41
Kim, J., Hong, S., Kim, S., Kim, D., Hur, D. Y., Jin, D., Kim, B., & Kim, Y. D. (2017) · International Journal of Oncology · doi:10.3892/ijo.2017.4227 · Cited by 41
Inhibition of PKC‐Induced COX‐2 and IL‐8 Expression in Human Breast Cancer Cells by Glucosamine
Chou, W., Chuang, K., Sun, D., Lee, Y., Kao, P., Lin, Y., Wang, H., & Wu, Y.-L. (2015) · Journal of Cellular Physiology · doi:10.1002/jcp.24955 · Cited by 40
Ko, S. C., Chapple, K. S., Hawcroft, G., Coletta, P. L., Markham, A. F., & Hull, M. A. (2002) · Oncogene · doi:10.1038/sj.onc.1205869 · Cited by 40
The inflammatory microenvironment that promotes gastrointestinal cancer development and invasion
Echizen, K., Oshima, H., Nakayama, M., & Oshima, M. (2018) · Advances in Biological Regulation · doi:10.1016/j.jbior.2018.02.001 · Cited by 40
Ikeya, S., Sakabe, J., Yamada, T., Naito, T., & TOKURA, Y. (2018) · Scientific Reports · doi:10.1038/s41598-018-23439-7 · Cited by 40
Prospective study of urinary prostaglandin E2 metabolite and pancreatic cancer risk
Cui, Y., Shu, X., Li, H., Yang, G., Wen, W., Gao, Y., Cai, Q., Rothman, N., Yin, H., Lan, Q., et al. (2017) · International Journal of Cancer · doi:10.1002/ijc.31007 · Cited by 39
Induction but not inhibition of COX-2 confers human lung cancer cell apoptosis by celecoxib
Ramer, R., Walther, U. I., Borchert, P., Laufer, S., Linnebacher, M., & Hinz, B. (2013) · Journal of Lipid Research · doi:10.1194/jlr.m042283 · Cited by 38
1,8-cineole prevents UVB-induced skin carcinogenesis by targeting the aryl hydrocarbon receptor
Lee, J., Ha, S. J., Park, J., Kim, Y. H., Lee, N. H., Kim, Y. E., Kim, Y., Song, K., & Jung, S. K. (2017) · Oncotarget · doi:10.18632/oncotarget.22519 · Cited by 38
Stromal COX-2 signaling are correlated with colorectal cancer: A review
Su, C., Zhang, Y., & Zhu, Y. (2016) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2016.08.010 · Cited by 37
Dinicola, S., Masiello, M. G., Proietti, S., Coluccia, P., Fabrizi, G., Catizone, A., Ricci, G., Toma, G. D., Bizzarri, M., & Cucina, A. (2017) · Journal of Cellular Physiology · doi:10.1002/jcp.26323 · Cited by 37
Goswami, S., & Sharma-Walia, N. (2016) · Oncotarget · doi:10.18632/oncotarget.9835 · Cited by 36
Role of SMAD proteins in colitis-associated cancer: from known to the unknown
Chandrasinghe, P. C., Cereser, B., Moorghen, M., Bakir, I. A., Tabassum, N., Hart, A., Stebbing, J., & Warusavitarne, J. H. (2017) · Oncogene · doi:10.1038/onc.2017.300 · Cited by 35
Adaptor protein p62 promotes skin tumor growth and metastasis and is induced by UVA radiation
Sample, A., Zhao, B., Qiang, L., & He, Y. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.786160 · Cited by 33
Acid-degradable Dextran as an Image Guided siRNA Carrier for COX-2 Downregulation
Chen, Z., Krishnamachary, B., Penet, M., & Bhujwalla, Z. M. (2017) · Theranostics · doi:10.7150/thno.21052 · Cited by 33
Rossi, E. L., Khatib, S. A., Doerstling, S. S., Bowers, L. W., Pruski, M. A., Ford, N. A., Glickman, R. D., Niu, M., Yang, P., Cui, Z., et al. (2017) · Molecular Carcinogenesis · doi:10.1002/mc.22763 · Cited by 33
Preventive Potential of Resveratrol in Carcinogen-Induced Rat Thyroid Tumorigenesis
Zheng, X., Jia, B., Song, X., Kong, Q., Wu, M., Qiu, Z., Li, H., & Liu, J. (2018) · Nutrients · doi:10.3390/nu10030279 · Cited by 33
Han, F., Ren, J., Zhang, J., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.9573 · Cited by 32
Zhao, Q., Guo, J., Wang, G., Chu, Y., & Hu, X. (2016) · Oncotarget · doi:10.18632/oncotarget.13774 · Cited by 32
Hull, M. A., Cuthbert, R. J., Ko, C. W. S., Scott, D. J., Cartwright, E. J., Hawcroft, G., Perry, S., Ingram, N., Carr, I., Markham, A. F., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-06253-5 · Cited by 31
Obermoser, V., Baecker, D., Schuster, C., Braun, V., Kircher, B., & Gust, R. (2018) · Dalton Transactions · doi:10.1039/c7dt04790h · Cited by 29
Li, F., & Zhu, Y. (2015) · Cellular Signalling · doi:10.1016/j.cellsig.2015.01.014 · Cited by 28
Specific role of RhoC in tumor invasion and metastasis
Lang, S., Busch, H. S., Boerries, M., Brummer, T., Timme, S., Laßmann, S., Aktories, K., & Schmidt, G. (2017) · Oncotarget · doi:10.18632/oncotarget.20957 · Cited by 27
MicroRNA-144 functions as a tumor suppressor in gastric cancer by targeting cyclooxygenase-2
Yao, Q., Gu, A., Wang, Z., & Xue, Y. (2018) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2018.5763 · Cited by 26
Text mining-based in silico drug discovery in oral mucositis caused by high-dose cancer therapy
Kirk, J., Shah, N. P., Noll, B. D., Stevens, C. B., Lawler, M., Mougeot, F. B., & Mougeot, J.-L. (2018) · Supportive Care in Cancer · doi:10.1007/s00520-018-4096-2 · Cited by 26
Soto, M. S., O’Brien, E. R., Andreou, K. E., Scrace, S., Zakaria, R., Jenkinson, M. D., O’Neill, E. E., & Sibson, N. R. (2016) · Oncotarget · doi:10.18632/oncotarget.10737 · Cited by 25
Dai, P., Li, J., Ma, X., Huang, J., Meng, J.-J., & Gong, P. (2018) · OncoTargets and Therapy · doi:10.2147/ott.s148670 · Cited by 25
Lang, S., Picu, A., Hofmann, T., Andratschke, M., Mack, B., Moosmann, A., Gires, O., Tiwari, S., & Zeidler, R. (2006) · International Journal of Immunopathology and Pharmacology · doi:10.1177/039463200601900217 · Cited by 24
SerpinB3 upregulates the Cyclooxygenase-2 / β-Catenin positive loop in colorectal cancer
Terrin, L., Agostini, M., Ruvoletto, M., Martini, A., Pucciarelli, S., Bedin, C., Nitti, D., & Pontisso, P. (2017) · Oncotarget · doi:10.18632/oncotarget.14997 · Cited by 24
Mechanisms of action of nonpeptide hormones on resveratrol‐induced antiproliferation of cancer cells
Lin, H., Hsieh, M.-T., Cheng, G., Lai, H.-Y., Chin, Y., Shih, Y.-J., Nana, A. W., Lin, S., Yang, Y. S. H., Tang, H., et al. (2017) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13423 · Cited by 24
Beeghly-Fadiel, A. C., Wilson, A. J., Keene, S. J., Ramahi, M. E., Xu, S., Marnett, L. J., Fadare, O., Crispens, M. A., & Khabele, D. (2018) · Journal of Ovarian Research · doi:10.1186/s13048-018-0389-9 · Cited by 24
Lü, Y., Shi, C., Qiu, S., & Fan, Z. (2016) · Oncotarget · doi:10.18632/oncotarget.8649 · Cited by 23
Baek, H., Park, N., Kwon, Y., Ye, D.-J., Shin, S., & Chun, Y. (2017) · Oncotarget · doi:10.18632/oncotarget.19392 · Cited by 23
Guo, Q., Liu, X., Lu, L., Yuan, H., Wang, Y., Chen, Z., Ji, R., & Zhou, Y. (2017) · Medicine · doi:10.1097/md.0000000000008857 · Cited by 23
Jeong, A., Kim, J., Lee, H., & Kim, S. (2017) · Oncotarget · doi:10.18632/oncotarget.19592 · Cited by 22
Cheng, H., Chu, L.-Y., Chiang, L., Chen, H., Kuo, C.-C., & Wu, K. K. (2016) · Oncotarget · doi:10.18632/oncotarget.9111 · Cited by 21
The metal-nonoate Ni(SalPipNONO) inhibitsin vitrotumor growth, invasiveness and angiogenesis
Ciccone, V., Monti, M., Monzani, E., Casella, L., & Morbidelli, L. (2018) · Oncotarget · doi:10.18632/oncotarget.24350 · Cited by 21
Yang, C., Tu, H., Wu, C., Chang, H., Chiang, W.-F., Shih, N.-C., Lee, Y.-S., Kao, S., & Chang, K. (2016) · Oral Oncology · doi:10.1016/j.oraloncology.2016.03.010 · Cited by 19
Hao, J., Xu, H., Luo, M., Yu, W., Chen, M., Liao, Y., Zhang, C., Zhao, X., Jiang, W. H., Hou, S., et al. (2017) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2017.07.850 · Cited by 19
Araujo-Mino, E. P., Patt, Y. Z., Murray-Krezan, C. M., Hanson, J. A., Bansal, P., Liem, B., Rajput, A., Fekrazad, M. H., Heywood, G., & Lee, F.-C. (2017) · The Oncologist · doi:10.1634/theoncologist.2017-0474 · Cited by 19
Tury, S., Becette, V., Assayag, F., Vacher, S., Benoist, C., Kamal, M. T., Marangoni, E., Bièche, I., Lerebours, F., & Callens, C. (2016) · Oncotarget · doi:10.18632/oncotarget.13200 · Cited by 15
Involvement of NF-κB in mediating the anti-tumour effects of combretastatins in T cells
Pollock, J. K., Greene, L. M., Nathwani, S. M., Kinsella, P., O’Boyle, N. M., Meegan, M. J., & Zisterer, D. M. (2018) · Investigational New Drugs · doi:10.1007/s10637-017-0543-z · Cited by 7
Cited by
Key chemokines direct migration of immune cells in solid tumors
Kohli, K., Pillarisetty, V. G., & Kim, T. S. (2022) · Cancer Gene Therapy · doi:10.1038/s41417-021-00303-x · Cited by 583
Diagnosis and Management of Barrett's Esophagus: An Updated ACG Guideline
Shaheen, N. J., Falk, G. W., Iyer, P. G., Souza, R. F., Yadlapati, R. H., Sauer, B. G., & Wani, S. (2022) · American Journal of Gastroenterology · doi:10.14309/ajg.0000000000001680 · Cited by 510
The therapeutic potential of targeting tryptophan catabolism in cancer
Opitz, C. A., Somarribas Patterson, L. F., Mohapatra, S. R., Dewi, D. L., Sadik, A., Platten, M., & Trump, S. (2020) · British Journal of Cancer · doi:10.1038/s41416-019-0664-6 · Cited by 300
The Multifaceted Role of Heme in Cancer
Fiorito, V., Chiabrando, D., Petrillo, S., Bertino, F., & Tolosano, E. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2019.01540 · Cited by 129
COX2 regulates senescence secretome composition and senescence surveillance through PGE2
Gonçalves, S., Yin, K., Ito, Y., Chan, A., Olan, I., Gough, S., Cassidy, L., Serrao, E., Smith, S., Young, A., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.108860 · Cited by 95
Metadata
- Authors
- Hashemi Goradel, N., Najafi, M., Salehi, E., Farhood, B., & Mortezaee, K.
- Venue
- Journal of Cellular Physiology
- Publisher
- Wiley
- Published
- 2018-10-20
- Volume
- 234
- Issue
- 5
- Pages
- 5683-5699
- ISSN
- 0021-9541 (ISSN-L)
- 1097-4652
- OpenAlex
- W2898079638
- Cited by
- 807
- References
- 147
- FWCI
- 35.44
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.